BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33268767)

  • 21. LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis.
    Xiao S; Song B
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32519740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ARID1B/SUB1-activated lncRNA HOXA-AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3.
    Liu G; Liu B; Liu X; Xie L; He J; Zhang J; Dong R; Ma D; Dong K; Ye M
    J Cell Mol Med; 2021 Apr; 25(7):3524-3536. PubMed ID: 33683826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA PART1 restrains aggressive gastric cancer through the epigenetic silencing of PDGFB via the PLZF-mediated recruitment of EZH2.
    Han H; Wang S; Meng J; Lyu G; Ding G; Hu Y; Wang L; Wu L; Yang W; Lv Y; Jia S; Zhang L; Ji J
    Oncogene; 2020 Oct; 39(42):6513-6528. PubMed ID: 32901105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer.
    Wang J; Su Z; Lu S; Fu W; Liu Z; Jiang X; Tai S
    Clin Chim Acta; 2018 Oct; 485():229-233. PubMed ID: 29981289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cells.
    Zhu XX; Yan YW; Chen D; Ai CZ; Lu X; Xu SS; Jiang S; Zhong GS; Chen DB; Jiang YZ
    Oncotarget; 2016 Sep; 7(39):63561-63570. PubMed ID: 27566578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The implication of lncRNA expression pattern and potential function of lncRNA RP4-576H24.2 in acute myeloid leukemia.
    Zheng J; Song Y; Li Z; Tang A; Fei Y; He W
    Cancer Med; 2019 Dec; 8(17):7143-7160. PubMed ID: 31568697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA HOXA-AS2 regulates microglial polarization via recruitment of PRC2 and epigenetic modification of PGC-1α expression.
    Yang X; Zhang Y; Chen Y; He X; Qian Y; Xu S; Gao C; Mo C; Chen S; Xiao Q
    J Neuroinflammation; 2021 Sep; 18(1):197. PubMed ID: 34511122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive investigation of the clinical significance of long non-coding RNA HOXA-AS2 in acute myeloid leukemia using genome-wide RNA sequencing dataset.
    Huang R; Liao X; Wang X; Li Q
    J Cancer; 2021; 12(7):2151-2164. PubMed ID: 33754013
    [No Abstract]   [Full Text] [Related]  

  • 29. Long noncoding RNA MEG3 regulates LATS2 by promoting the ubiquitination of EZH2 and inhibits proliferation and invasion in gallbladder cancer.
    Jin L; Cai Q; Wang S; Wang S; Mondal T; Wang J; Quan Z
    Cell Death Dis; 2018 Oct; 9(10):1017. PubMed ID: 30282996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA HOXA-AS2 promotes cell migration and invasion via upregulating IGF-2 in non-small cell lung cancer as an oncogene.
    Zheng FX; Wang XQ; Zheng WX; Zhao J
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4793-4799. PubMed ID: 31210310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis.
    Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W
    Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long Non-Coding RNA HOXA-AS2 Enhances The Malignant Biological Behaviors In Glioma By Epigenetically Regulating RND3 Expression.
    Wu L; Zhu X; Song Z; Chen D; Guo M; Liang J; Ding D; Wang W; Yan D
    Onco Targets Ther; 2019; 12():9407-9419. PubMed ID: 31819475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA ADAMTS9-AS2 promotes tongue squamous cell carcinoma proliferation, migration and EMT via the miR-600/EZH2 axis.
    Li Y; Wan Q; Wang W; Mai L; Sha L; Mashrah M; Lin Z; Pan C
    Biomed Pharmacother; 2019 Apr; 112():108719. PubMed ID: 30970517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microarray Analysis of Long Non-Coding RNAs in Lung Tissues of Patients with COPD and HOXA-AS2 Promotes HPMECs Proliferation via Notch1.
    Zhou AY; Zhao YY; Zhou ZJ; Duan JX; Zhu YZ; Cai S; Chen P
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2449-2460. PubMed ID: 33116460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HOXA cluster antisense RNA 2 elevates KIAA1522 expression through microRNA-520d-3p and insulin like growth factor 2 mRNA binding protein 3 to promote the growth of vascular smooth muscle cells in thoracic aortic aneurysm.
    Ou M; Chu Y; Zhang Q; Zhao H; Song Q
    ESC Heart Fail; 2022 Oct; 9(5):2955-2966. PubMed ID: 35730141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway.
    Zhao Q; Zhao S; Li J; Zhang H; Qian C; Wang H; Liu J; Zhao Y
    Biomed Pharmacother; 2019 Jan; 109():1640-1649. PubMed ID: 30551418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori infection induces gastric cancer cell malignancy by targeting HOXA-AS2/miR-509-3p/MMD2 axis.
    Cheng S; Jia Y; Wu J; Li J; Cao Y
    Genes Genomics; 2024 Jun; 46(6):647-657. PubMed ID: 38573409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LINC00978 promotes the progression of hepatocellular carcinoma by regulating EZH2-mediated silencing of p21 and E-cadherin expression.
    Xu X; Gu J; Ding X; Ge G; Zang X; Ji R; Shao M; Mao Z; Zhang Y; Zhang J; Mao F; Qian H; Xu W; Cai H; Wang F; Zhang X
    Cell Death Dis; 2019 Oct; 10(10):752. PubMed ID: 31582742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3.
    Sun J; Wang L
    BMC Cancer; 2022 Apr; 22(1):366. PubMed ID: 35387643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.